Clinical Trials Browser

Phase 1 × Lymphoma, Large B-Cell, Diffuse × abexinostat × Clear all

NCT03939182 2025-04-25

Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma

Phase 1 Completed

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell